
pmid: 31347346
handle: 11392/2592872
Mesenchymal stem cells (MSCs) are able to exert immunomodulatory and anti-inflammatory actions. Thanks to these properties, MSCs may be a promising alternative approach for the treatment of inflammatory disease. Important cytokines involved in inflammation are those included in the IL-1 family. Interleukin-37 (IL-37) is one of the member able to suppress both innate and adaptive immunity. Recently, it was found that MSCs and their derivatives can modulate IL-37, and MSCs expressing IL-37 seem to have an enhanced therapeutic efficacy.
IL-37; Inflammation; Mesenchymal stem cells;, Inflammation, mesenchymal stem cells, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, IL-37, inflammation, Cytokines, Humans, Interleukin-1
IL-37; Inflammation; Mesenchymal stem cells;, Inflammation, mesenchymal stem cells, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, IL-37, inflammation, Cytokines, Humans, Interleukin-1
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
